BCL2 and non-small cell lung carcinoma: In this study, we focused to BCL2 protein as a second therapeutic target for NSCLC since we found the overexpression of the BCL2 protein in WT and G1202R, while C1156Y and L1196M showed BCL2 closely to basal expression.